What is Siegfried Holding Ltd (SFZN.SW)?
Siegfried Holding Ltd trades as SFZN.SW on the SW exchange (Switzerland) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-11-11.
Is SFZN.SW in a Closelooknet index?
Not currently — Siegfried Holding Ltd is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-11-11.
What is Siegfried Holding Ltd's Closelooknet composite score?
43 out of 100, with momentum 32, quality 44 and valuation 54 sub-scores, as of 2026-11-11. Scores are Closelooknet's own research readings, not ratings or investment advice.
Where does SFZN.SW trade against its moving averages?
Siegfried Holding Ltd trades 0.2% below its 50-day and 6.9% below its 200-day moving average (0.8% below its 20-day). As of 2026-11-10 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.
How does Siegfried Holding Ltd compare with its peers?
Against its peer group (Drug Manufacturers - Specialty & Generic), Siegfried Holding Ltd (SFZN.SW) sits 29.3% below its 52-week high, 0.2% below its 50-day average; Laboratorios Farmaceuticos ROVI (ROVI.MC) is 18.6% below, Ironwood Pharmaceuticals Inc (IRWD) is 16.8% below, Lantheus Holdings Inc (LNTH) is 9.2% below, as of 2026-11-10. Put any of them next to SFZN.SW in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.
What does Siegfried Holding Ltd do?
Siegfried Holding is a Swiss contract manufacturer that develops and produces active pharmaceutical ingredients and finished drug products for other pharmaceutical companies. Its work spans custom chemical synthesis, sterile fill-and-finish, inhalation and oral dosage forms, and manufacturing of viral vectors for gene therapy. It is based in Zofingen, Switzerland, and operates as an outsourced production partner to drugmakers worldwide. Closelooknet's peer group holds no comparison set for this name. The market most often sets it beside Lonza, the larger contract manufacturer active in similar drug-substance and drug-product work. (Company snapshot of 2026-09-17.)
Where does Siegfried Holding Ltd sit in the AI build-out?
Siegfried holds no seat in Rubin, our AI compute index, or in Halo; it sits outside the diary's AI-linked sleeves entirely. It is tracked instead as a pharmaceutical contract manufacturer within the healthcare sector of our wider universe, not against any build-out layer. Siegfried carries no index seat and no Closelooknet score; the score-building process has not started for this name. The diary has not quoted it in any edition so far, and it appears in no Rubin or Halo reading. (Company snapshot of 2026-09-17.)
Does Siegfried Holding Ltd pay a dividend?
Siegfried Holding Ltd has paid 0.40 CHF per share over the last twelve months, paid once a year, a trailing yield of 0.56% on the 2026-11-10 close; the last distribution recorded in the price series was 0.40 CHF on 2026-04-28. In fiscal 2025 the company paid 17 m CHF in dividends and bought back 1 m CHF of its own shares, 180% of that year’s free cash flow. The share count rose 0.8% over the fiscal year. As of 2026-11-10; the "Dividends and capital return" block on this page carries the lines.
What does this page show?
A live price chart with SMA overlays and drawing tools for SFZN.SW, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.